Member Info for BOJO2020

In2win, give it a rest, you are as bad as the wife!!!

Sure, give me facts and figures all day long but I not fussed about your feelings. All a frightfully whiney if you ask me. I will forgive you your rudeness as you have clearly had an exciting day. Hope to see you and everyone else invested here with plenty of dosh and a safer world in future.

Lets have it right, the RNS was reasonable news but the reaction has been overboard and now I have plenty of shiny euros Mwhahahaha!!!

Told you Boohoo were alright! Whoop Whoop!!!

Not keen on the Boohoo chaps but I am not crying now!!

Lets put this to bed once and for all and move on please.

The original question was, 'Why hasn't the share price increased based on this news.' (RNS)

The answer is that nothing material has changed. That is to say that no tests have been sold etc. If there were material differences then the Markets would have reacted. As there were none the markets ignored it. That is the beginning and end of the matter. Question asked and question answered.

Might I suggest that you change your rose-tinted spectacles and start to look at trading through a prism of pounds and dollars. You will make more and lose less this way IMO.

I would also like to make it clear that I believe that Avacta are doing a grand job and will become successful. The Boohoo boys will have to make their own arrangements and if they can cut the mustard and give Medusa 19 legs - good on them. They may yet be of benefit to Avacta and the general public, but appreciate they are at the very beginning of their venture and I wish them good luck.

Copy and then paste the entire link from the search bar

This deal in the grand scheme of things is irrelevant. The MM will not consider this anything more than a publicity stunt and therefore will not amend the SP. That will happen but not because of MEDUSA 19. They have alot to prove.

I think the RNS will come at any time but not any time soon. Once the cat is out of the bag SNG will have to issue an RNS. The timing, therefore, may not suit everyone. Rest assured that the PI will be the last to know. No matter what I will remain loyal to my research and the good work of the Company.

The share price has not risen. Well, a lot can affect the share price but the bottom line is that the MM is not particularly interested in a brand new start-up (Medusa 19) hooking up with an up and coming Bio-Pharm firm that has yet an unproven test kit.

Don't get me wrong, love Avacta and what they are doing but this does not float any one's boat - not anybody that matters anyway. I have basically decided to ignore the RNS and I await proper news as does the main market.

BOD you must do better, the Company deserves better.

When the Kumar Brothers bought into Birmingham City, or when the Gold brothers bought into Birmingham City or when Carsen Yueng bought into Birmingham City.

Ohh the flash backs! Oh Cripes...

Good luck to rainbow chasers! If they are investing that is a good thing and it should not be discouraged. With the exception of the pump and dump crews.

If we get good news it will top 60p. A long way to go and many more increments to achieve crazy predictions. This will take some time so IMO find something to do.

For me, this sounds like all or nothing. This distribution deal gets the test to the end-user. The other route, of course, would have been via the government. Whilst HMG is somewhat dithering with the scale of Covid, at least our board have decided to take it to market. The decisiveness should be commended.

Only thing is, if the government comes in with an offer at some stage ( likely to be much later) then boohoo are not going to be happy.

A lot of the Bio firms are seeing reduced volumes of trades (no of transactions). Maybe this is to be expected as they have had a moment in the spotlight due to Covid. Many have blossomed and others have yet too. I think most pi are moving onto the next thing and some have spent their ISA funds. Some are just waiting for imminent results. When there is something to shout about they will be back.

IMO Hemo can build on its success and relationships built over this period but it is not quite as far along the line as the others. That is not a bad thing as it means the share price is relatively inexpensive. The chances are that holding may well pay off in the longer term. On the other hand Vlad may have something up his sleeve (besides his armpit) Just my opinion.

I like many am already looking toward the winter with a degree of trepidation. The Government has done its best, but all things considered, it has not coped very well. There will be no excuses come wintertime.

In terms of ODX and others, we will have two bites at the cherry, right now and come the winter flu season. Let's just hope not too many lives are lost and affected by then...

Breaking News: Paul Gasgoine signs for Italian Football Club Lazio.

Shoot! Cytiva have more collaborations than I have stakes in Bio Companies! Looks like the Avacta connection is a good one.

Not too bothered about the price but I am taking some comfort from the slight upswings.

I have holdings in AVCT, SNG, GDR and ODX. All of the aforementioned are dependent on results whereas the holdings I have in HMEO and SCLP are not. So for me, there is no pressure on Hemo. Potentially I stand to lose if SNG, GDR and ODX do not deliver but I have already covered potential losses elsewhere.

IMO Hemo is a pretty safe bet at 7p plus. Whether anything comes of it I don't know but it looks to good and opportunity to ignore at this price and a small investment. DYOR.

Intriguing! I think one way or another SNG will be just fine.